New Schroders fund benefits Cancer Research Campaign

Howard Lake | 14 May 2000 | News

Schroders have launched a new fund that invests in the healthcare sector, offering investors a change “to benefit from the huge investment potential of medical research.”. In addition, the Schroder Medical Discovery Fund will benefit the work of the Cancer Research Campaign. Schroders will contribute half of the net initial charge (inclusive of VAT) and 0.25% of the total value of the fund (inclusive of VAT) to the CRC annually on an ongoing basis.

Find out more about the Schroder Medical Discovery Fund.

About Howard Lake
Howard Lake is consultant editor of UK Fundraising. He founded the site in 1994 and successfully sold it in 2022. As director of Giving X Ltd he is exploring growing giving on a massive scale. He is the founder of Fundraising Camp and co-founder of GoodJobs.